Abbott price target lowered to $105 from $115 at Mizuho

Mizuho lowered the firm’s price target on Abbott to $105 from $115 and keeps a Neutral rating on the shares. The analyst lower targets on several medical technology names ahead of the Q3 earnings season to reflect inputs from hospital/physician surveys and key opinion leader channel checks. The target drops account for the sharp intra-quarter contraction driven in part by GLP-1 risk concerns, the analyst tells investors in a research note.